Dr. Pant on the Third-Line Setting for Metastatic CRC

Name: Dr. Pant on the Third-Line Setting for Metastatic CRC
Uploaded: 2017-12-06T03:34:00.000Z
Description: Shubham Pant, MD, associate professor, The University of Texas MD Anderson Cancer Center, discusses the third-line setting for patients with metastatic colorectal cancer (CRC).

December 5, 2017

Shubham Pant, MD

Article

Shubham Pant, MD, associate professor, The University of Texas MD Anderson Cancer Center, discusses the third-line setting for patients with metastatic colorectal cancer (CRC).

According to Pant, there are not many options for patients with CRC in the third-line setting. Currently, regorafenib (Stivarga) and TAS-102 are the only options for this setting.

Next-generation sequencing is important to determine targets for treatment, explains Pant.